Comparative Membranome Expression Analysis in Primary Tumors and Derived Cell Lines
Paolo Uva(Environment Park), Emanuele de Rinaldis(Target (United States)), Armin Lahm(IRBM Science Park), Andrea Sbardellati, Anita Grigoriadis(London Cancer), Andrew Tutt(Institute of Cancer Research)
Cited by 21
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k